A Phase I Study of NK042 Cell Injection in Advanced Solid Tumors

NCT06773091 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: NK042
DRUG: Fludarabine (FLU)
DRUG: Cyclophosphamide (CTX)

Sponsor

Shanghai NK Cell Technology Co., LTD